Bath & Body Works Cash Flow Statement

Financials in millions USD. Fiscal year is February - January.

Millions USD. Fiscal year is Feb - Jan.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 2, 2026	Jan '26 Jan 31, 2026	Feb '25 Feb 1, 2025	Feb '24 Feb 3, 2024	Jan '23 Jan 28, 2023	Jan '22 Jan 29, 2022
Net Income	727	649	798	878	800	1,333
Depreciation & Amortization	251	254	282	269	221	363
Stock-Based Compensation	29	31	40	43	38	46
Other Adjustments	-54	55	-141	-154	17	240
Change in Receivables	-39	25	18	2	11	-64
Changes in Inventories	-275	37	-26	-2	-	-177
Changes in Accounts Payable	233	111	-50	-109	44	-86
Changes in Income Taxes Payable	15	-57	-23	34	39	-72
Changes in Other Operating Activities	7	-3	-12	-7	-26	-91
Operating Cash Flow	1,158	1,102	886	954	1,144	1,492
Operating Cash Flow Growth	16.03%	24.38%	-7.13%	-16.61%	-23.32%	-26.83%
Capital Expenditures	-249	-237	-226	-298	-328	-270
Sale of Property, Plant & Equipment	-	9	-	-	-	-
Proceeds from Sale of Investments	-	-	40	-	-	-
Other Investing Activities	2	1	24	12	-	11
Investing Cash Flow	-230	-227	-162	-286	-328	-259
Long-Term Debt Repaid	-289	-14	-539	-462	-9	-1,728
Net Long-Term Debt Issued (Repaid)	-289	-14	-539	-462	-9	-1,728
Issuance of Common Stock	-	-	-	-	-	83
Repurchase of Common Stock	-265	-401	-401	-148	-1,312	-1,964
Net Common Stock Issued (Repurchased)	-265	-401	-401	-148	-1,312	-1,881
Common Dividends Paid	-164	-167	-177	-182	-186	-120
Other Financing Activities	-14	-17	-15	-23	-55	541
Financing Cash Flow	-746	-599	-1,132	-815	-1,562	-3,188
Effect of Exchange Rate Changes on Cash and Cash Equivalents	2	3	-2	-1	-1	1
Net Cash Flow	184	279	-410	-148	-747	-1,954
Free Cash Flow	909	865	660	656	816	1,222
Free Cash Flow Growth	5.09%	31.06%	0.61%	-19.61%	-33.22%	-32.52%
FCF Margin	12.55%	11.86%	9.03%	8.83%	10.79%	15.50%
Free Cash Flow Per Share	4.42	4.14	2.99	2.86	3.50	4.48
Levered Free Cash Flow	420	740	204	303	741	-728
Unlevered Free Cash Flow	907.27	933.54	927.75	992.02	1,657	2,167

SEC Filings: 10-K · 10-Q